Table 2 Melanoma cohort
Cohort population (112) | CIP group 4% (5) | No CIP group 96% (107) |
|---|---|---|
Median age | 58 | 60 |
Male sex | 60% | 51% |
Former or current smoker status | 80% | 35% |
COPD | 20% | 18% |
BRAF V600 | 20% | 46% |
Lung involvement | 60% | 49% |
PD1 inhibitors as treatment regimen | 80% | 76% |
ORR | 100% | 38% |